Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Asset Writedowns and Impairment (2022)

Historic Asset Writedowns and Impairment for Core Scientific (CORZ) over the last 1 years, with Q4 2022 value amounting to $3.1 million.

  • Core Scientific's Asset Writedowns and Impairment changed N/A to $3.1 million in Q4 2022 from the same period last year, while for Dec 2023 it was $9.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $9.0 million for FY2022, which is N/A changed from last year.
  • Core Scientific's Asset Writedowns and Impairment amounted to $3.1 million in Q4 2022.
  • Core Scientific's Asset Writedowns and Impairment's 5-year high stood at $790.8 million during Q2 2022, with a 5-year trough of -$784.9 million in Q3 2022.